Buoyant Capital bought 9,60,000 shares of Indegene Limited for ₹50.40 Cr at ₹525.00 apiece in a block deal.
A provider of analytics, technology, and specialized services to life science and healthcare organizations worldwide. Indegene delivers integrated solutions spanning commercial, medical, regulatory, and safety domains, combining data-driven insights with advanced technology platforms. The company serves pharmaceutical, biotech, and healthcare firms seeking to optimize operations, enhance decision-making, and improve market performance through evidence-based approaches and digital transformation.
Mumbai-based founded in 2016. Runs cycle-aware multi-cap strategies. Led by Jigar Mistry (ex-Director Research at HSBC), Sachin Khivasara, and Viral Berawala.